Literature DB >> 17598094

New onset of atrial fibrillation after introduction of azathioprine in ulcerative colitis: case report and review of the literature.

Andrea Cassinotti1, Alessandro Massari, Elisa Ferrara, Salvatore Greco, Matteo Bosani, Sandro Ardizzone, Gabriele Bianchi Porro.   

Abstract

CASE REPORT: We present the case of a 52-year-old man with steroid-dependent ulcerative colitis, needing immunosuppressive therapy with azathioprine. The drug had been started 3 years earlier, but stopped after a few months because the patient reported palpitations, lipothymia, nausea and vomiting. Given the continued steroid-dependent ulcerative colitis and the lack of clinical documentation about a reaction with a dubious relationship to azathioprine, we decided to rechallenge the patient with the drug under clinical monitoring and after informed consent. After starting 50 mg of azathioprine, the patient showed general malaise, nausea and vomiting. An ECG showed atrial fibrillation, and the patient reported that the symptoms were similar to those previously experienced. DISCUSSION: We have found two other cases of similar onset of atrial fibrillation after azathioprine use, although some confounding elements in these episodes make the possible causal relationship between the drug and this adverse event uncertain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598094     DOI: 10.1007/s00228-007-0328-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

2.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Authors:  A Kandiel; A G Fraser; B I Korelitz; C Brensinger; J D Lewis
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

3.  Fast atrial fibrillation induced by treatment of psoriasis with azathioprine.

Authors:  H J Dodd; F M Tatnall; I Sarkany
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

4.  Fast atrial fibrillation induced by azathioprine.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

5.  Azathioprine-induced shock.

Authors:  T Cunningham; D Barraclough; K Muirden
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

6.  Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.

Authors:  Konstantinos P Letsas; Antonios Sideris; Stavros P Kounas; Michalis Efremidis; Panagiotis Korantzopoulos; Fotios Kardaras
Journal:  Int J Cardiol       Date:  2005-06-01       Impact factor: 4.164

7.  Cyclosporin effect on sodium and potassium transport across erythrocytes in rheumatoid arthritis.

Authors:  R A Rabini; I Testa; A Corvetta; M Lombardello; M Polenta; G Danieli; L Mazzanti
Journal:  Scand J Rheumatol       Date:  1990       Impact factor: 3.641

8.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

Review 9.  Review article: the management of steroid dependency in ulcerative colitis.

Authors:  G Bianchi Porro; A Cassinotti; E Ferrara; G Maconi; S Ardizzone
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

10.  Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients.

Authors:  L Frost; H Danielsen; I Dørup; T Kjaer; E B Pedersen
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

View more
  9 in total

1.  Prolonged QT dispersion in inflammatory bowel disease.

Authors:  Elif Yorulmaz; Aslıhan Sezgin; Hatice Yorulmaz; Gupse Adali; Hilmi Ciftci
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

2.  A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement.

Authors:  Mario Curione; Annalisa Aratari; Silvia Amato; Marco Colotto; Maria Barbato; Silvia Leone; Andi Tego; Diego Panetti; Claudio Parlapiano
Journal:  Intern Emerg Med       Date:  2010-04-22       Impact factor: 3.397

3.  Azathioprine-induced atrial fibrillation.

Authors:  Pinar Dogan; Enis Grbovic; Sinan Inci; Fatih Bayraktar; Kumral Cagli
Journal:  Intractable Rare Dis Res       Date:  2015-11

Review 4.  Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review.

Authors:  Homa Nomani; Amir Hooshang Mohammadpour; Seyed Mohammad Hassan Moallem; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2019-10-31       Impact factor: 4.473

Review 5.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

6.  Atopic dermatitis and risk of atrial fibrillation or flutter: A 35-year follow-up study.

Authors:  Sigrun A J Schmidt; Morten Olsen; Morten Schmidt; Christian Vestergaard; Sinéad M Langan; Mette S Deleuran; Jette L Riis
Journal:  J Am Acad Dermatol       Date:  2019-08-20       Impact factor: 11.527

7.  Mendelian randomization as an approach to assess causal effects of inflammatory bowel disease on atrial fibrillation.

Authors:  LaiTe Chen; GuoSheng Fu; ChenYang Jiang
Journal:  Aging (Albany NY)       Date:  2021-04-06       Impact factor: 5.682

Review 8.  Cardiovascular effects of immunosuppression agents.

Authors:  Aly Elezaby; Ryan Dexheimer; Karim Sallam
Journal:  Front Cardiovasc Med       Date:  2022-09-21

Review 9.  Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.

Authors:  Bruno Rafael Ramos de Mattos; Maellin Pereira Gracindo Garcia; Julia Bier Nogueira; Lisiery Negrini Paiatto; Cassia Galdino Albuquerque; Caique Lopes Souza; Luís Gustavo Romani Fernandes; Wirla Maria da Silva Cunha Tamashiro; Patricia Ucelli Simioni
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.